» Articles » PMID: 37996496

Interpretable Unsupervised Learning Enables Accurate Clustering with High-throughput Imaging Flow Cytometry

Overview
Journal Sci Rep
Specialty Science
Date 2023 Nov 23
PMID 37996496
Authors
Affiliations
Soon will be listed here.
Abstract

A primary challenge of high-throughput imaging flow cytometry (IFC) is to analyze the vast amount of imaging data, especially in applications where ground truth labels are unavailable or hard to obtain. We present an unsupervised deep embedding algorithm, the Deep Convolutional Autoencoder-based Clustering (DCAEC) model, to cluster label-free IFC images without any prior knowledge of input labels. The DCAEC model first encodes the input images into the latent representations and then clusters based on the latent representations. Using the DCAEC model, we achieve a balanced accuracy of 91.9% for human white blood cell (WBC) clustering and 97.9% for WBC/leukemia clustering using the 3D IFC images and 3D DCAEC model. Above all, although no human recognizable features can separate the clusters of cells with protein localization, we demonstrate the fused DCAEC model can achieve a cluster balanced accuracy of 85.3% from the label-free 2D transmission and 3D side scattering images. To reveal how the neural network recognizes features beyond human ability, we use the gradient-weighted class activation mapping method to discover the cluster-specific visual patterns automatically. Evaluation results show that the automatically identified salient image regions have strong cluster-specific visual patterns for different clusters, which we believe is a stride for the interpretable neural network for cell analysis with high-throughput IFCs.

Citing Articles

Predicting cell properties with AI from 3D imaging flow cytometer data.

Zhang Z, Zhu Y, Lai Z, Zhou M, Chen X, Tang R Sci Rep. 2025; 15(1):5715.

PMID: 39962067 PMC: 11833109. DOI: 10.1038/s41598-024-80722-6.

References
1.
Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

2.
Wang X, Li S . Protein mislocalization: mechanisms, functions and clinical applications in cancer. Biochim Biophys Acta. 2014; 1846(1):13-25. PMC: 4141035. DOI: 10.1016/j.bbcan.2014.03.006. View

3.
Chandran S, Klebanoff C . T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance. Immunol Rev. 2019; 290(1):127-147. PMC: 7027847. DOI: 10.1111/imr.12772. View

4.
Nakayasu E, Gritsenko M, Piehowski P, Gao Y, Orton D, Schepmoes A . Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation. Nat Protoc. 2021; 16(8):3737-3760. PMC: 8830262. DOI: 10.1038/s41596-021-00566-6. View

5.
Chen Y, Chen C, Riley D, Allred D, Chen P, Von Hoff D . Aberrant subcellular localization of BRCA1 in breast cancer. Science. 1995; 270(5237):789-91. DOI: 10.1126/science.270.5237.789. View